Catalyst Wire Dossier Catalyst Wire Dossier

HYALUBRIX 60

hyaluronic acid · Fidia Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HYALUBRIX 60, covering 2024-07-29 to 2024-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Efficacy of a Single Intra-articular Injection of HYALUBRIX 60 in Knee Osteoarthritis [NA]

See pricing